General Information of the Compound
Compound ID
CP0255475
Compound Name
(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol
    Show/Hide
Synonyms
(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol
CHEMBL594669
SCHEMBL4442909
    Show/Hide
Structure
Formula
C16H17N5O2
Molecular Weight
311.345
Canonical SMILES
OCc1ccc(cc1)-c1nc(N2CCOCC2)c2[nH]cnc2n1
    Show/Hide
InChI
InChI=1S/C16H17N5O2/c22-9-11-1-3-12(4-2-11)14-19-15-13(17-10-18-15)16(20-14)21-5-7-23-8-6-21/h1-4,10,22H,5-9H2,(H,17,18,19,20)
    Show/Hide
InChIKey
GSYUMLARWMDMOF-UHFFFAOYSA-N
Physicochemical Property
logP
1.3488
Rotatable Bonds
3
Heavy Atom Count
23
Polar Areas
87.16
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25069592
SID: 56407821
ChEMBL ID
CHEMBL594669
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 4500 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( (4-(6-morpholino-9H-purin-2-yl)phenyl)methanol )
Drug Name (4-(6-morpholino-9H-purin-2-yl)phenyl)methanol
Target(s)
Serine/threonine-protein kinase mTOR (mTOR)
Inhibitor